Coronavirus disease 2019 (COVID-19) has rapidly become a global pandemic and no antiviral
drug or vaccine is yet available for the treatment of this disease 1 , 2 – 3 . Several clinical …

Nucleoside analogues display significant anticancer or antiviral activity by interfering with
DNA synthesis. However, there are some serious restrictions to their use, including their rapid …

Two of the crucial aspects of human immunodeficiency virus (HIV) infection are (i) viral
persistence in reservoirs (precluding viral eradication) and (ii) chronic inflammation (directly …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is continuing
to disrupt personal lives, global healthcare systems, and economies. Hence, there is an …

Malaria relapses, resulting from the activation of quiescent hepatic hypnozoites of Plasmodium
vivax and Plasmodium ovale, hinder global efforts to control and eliminate malaria. As …

Background Amongst the Plasmodium species in humans, only P. vivax and P. ovale produce
latent hepatic stages called hypnozoites, which are responsible for malaria episodes long …

Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …

Inducing antigen-specific tolerance during an established immune response typically requires
non-specific immunosuppressive signalling molecules. Hence, standard treatments for …

The current pandemic of coronavirus disease (COVID) 2019 constitutes a global public
health issue. Regarding the emerging importance of the gut-lung axis in viral respiratory …

Background. Persistent low CD4 + cell counts are observed in 5%–27% of patients treated
for human immunodeficiency virus (HIV)—1 infection despite their having prolonged …